Abstract
ABSTRACT
An estimated 21.5% of patients in the United States who have had COVID-19 report development of a prolonged postviral syndrome that has been called postacute sequelae of COVID-19 (PASC). Symptoms can range from very mild to debilitating damage to organ systems caused directly by the virus and indirectly by the body's inflammatory response. Research into defining PASC and discovering effective treatments is ongoing. This article discusses the common presentations of PASC in patients who have had COVID-19; describes specific effects on the pulmonary, cardiovascular, and central nervous systems; and identifies potential treatments based on current literature.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference22 articles.
1. How and why patients made long COVID;Callard;Soc Sci Med,2021
2. Update to post-acute sequelae of SARS-CoV-2 infection: caring for the ‘long-haulers.’;Vehar;Cleve Clin J Med
3. COVID-19 myocarditis and prospective heart failure burden;Shchendrygina;Expert Rev Cardiovasc Ther,2021
4. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC);Sherif;eLife,2023
5. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments;Yong;Infect Dis (Lond),2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献